Max Kurlbaum
Impact in
-
- Hormonal Regulation and Hypertension
- Pituitary Gland Disorders and Treatments
- Adrenal Hormones and Disorders
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Surgery 26
- Adrenal and Paraganglionic Tumors 23
-
- Hormonal Regulation and Hypertension 17
- Pituitary Gland Disorders and Treatments 9
- Adrenal Hormones and Disorders 6
- Co-authors
- Martin Faßnacht (24 shared papers)Matthias Kroiß (18 shared papers)Petra Högger (2 shared papers)Timo Deutschbein (6 shared papers)Oliver Scherf‐Clavel (12 shared papers)Sabine Kendl (9 shared papers)Stefanie Hahner (7 shared papers)Graeme Eisenhofer (5 shared papers)
- Journals
- European Journal of Endocrinology (5 papers)Frontiers in Endocrinology (3 papers)Analytical and Bioanalytical Chemistry (2 papers)Therapeutic Drug Monitoring (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)
- Partner nations
- GermanyNetherlandsSwitzerland
In The Last Decade
Max Kurlbaum
40 papers receiving 595 citations
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 259
- Cancer Research 148
- Applied Microbiology and Biotechnology 18
- Genetics 67
- Surgery 277
Countries citing papers authored by Max Kurlbaum
This map shows the geographic impact of Max Kurlbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Kurlbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Kurlbaum more than expected).
Fields of papers citing papers by Max Kurlbaum
This network shows the impact of papers produced by Max Kurlbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Kurlbaum. The network helps show where Max Kurlbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Kurlbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 60 | |
| 2 | 2018 | 57 | |
| 3 | 2020 | 46 | |
| 4 | 2021 | 40 | |
| 5 | 2010 | 39 | |
| 6 | 2020 | 34 | |
| 7 | 2013 | 25 | |
| 8 | 2021 | 22 | |
| 9 | 2015 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2020 | 20 | |
| 12 | 2019 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 2016 | 13 | |
| 16 | 2016 | 13 | |
| 17 | 2018 | 13 | |
| 18 | 2023 | 11 | |
| 19 | 2023 | 10 | |
| 20 | 2021 | 10 |
About Max Kurlbaum
Max Kurlbaum is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cancer Research, Genetics and Molecular Biology, having authored 47 papers that have together received 603 indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (23 papers), Hormonal Regulation and Hypertension (17 papers), Cancer, Hypoxia, and Metabolism (11 papers), Pituitary Gland Disorders and Treatments (9 papers), Adrenal Hormones and Disorders (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (259 citations), Cancer Research (148 citations), Applied Microbiology and Biotechnology (18 citations), Genetics (67 citations) and Surgery (277 citations). Max Kurlbaum has collaborated with scholars based in Germany, Netherlands and Switzerland. Frequent co-authors include Martin Faßnacht, Matthias Kroiß, Petra Högger, Timo Deutschbein, Oliver Scherf‐Clavel, Sabine Kendl, Stefanie Hahner, Graeme Eisenhofer, Hartwig Klinker and Mirko Peitzsch. Their work appears in journals such as European Journal of Endocrinology, Frontiers in Endocrinology, Analytical and Bioanalytical Chemistry, Therapeutic Drug Monitoring and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.